Mantle Cell Lymphoma is a type of non-Hodgkin lymphoma characterized by abnormal B-cells in the lymph nodes, spleen, and bone marrow. The ICD-10 code for Mantle Cell Lymphoma is C83.1. In the previous coding system, the ICD-9 code for this condition was 200.3. These codes are used for medical billing, research, and documentation purposes to classify and track diseases.
Mantle cell lymphoma (MCL) is a rare and aggressive form of non-Hodgkin lymphoma that primarily affects the lymph nodes. It arises from abnormal B-lymphocytes in the mantle zone, which is a part of the lymph node. The International Classification of Diseases, 10th Revision (ICD-10), provides a specific code for Mantle Cell Lymphoma.
The ICD-10 code for Mantle Cell Lymphoma is C83.1. The "C" indicates that it is a malignant neoplasm, while "83" represents the category for non-Hodgkin lymphoma. The number "1" following the decimal point signifies that it is a subtype of non-Hodgkin lymphoma, specifically Mantle Cell Lymphoma.
On the other hand, the International Classification of Diseases, 9th Revision (ICD-9), is an older coding system that has been replaced by ICD-10. However, for reference purposes, the ICD-9 code for Mantle Cell Lymphoma was 200.4. The "200" series in ICD-9 refers to lymphoma and leukemia, and the ".4" indicates the specific subtype, which is Mantle Cell Lymphoma.
It is important to note that healthcare providers and institutions have transitioned to using ICD-10 codes as per the World Health Organization's guidelines. This transition allows for greater specificity and accuracy in diagnosing and coding medical conditions, facilitating better patient care, research, and data analysis.